Research Article

Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations

Table 4

Estimates yielded from multiple regression analysis to predict factors associated with quality of life measures.

COPDACO
CATEQ-5D VASCATEQ-5D VAS

Age-0.0180.0210.0310.171
Gender
 MaleRef.Ref.Ref.Ref.
 Female0.403-3.617a0.177-4.327
Body mass index (kg/m2)
 <200.5491.820-1.351-0.773
 20-24.9Ref.Ref.Ref.Ref.
 25.0-29.90.863-2.160-1.891-2.669
 >300.769-0.471-3.407d-7.136
Smoking status
 Current0.7810.653-0.034-0.491
 Ex-smokerRef.Ref.Ref.Ref.
Pack-years0.029a-0.094a-0.006-0.238a
Educational level
 LowRef.Ref.Ref.Ref.
 Medium-0.4524.208b-0.5943.009
 High-0.9031.441-1.04610.372e
No. of hospitalizations and ER visits due to exacerbation in the past year
 0Ref.Ref.Ref.Ref.
 1-0.7220.058-2.598-0.262
  ≥ 22.257b-0.443-6.772a-6.430
FEV1 (% reference)-0.0240.072-0.0490.143
Comorbidities
 Absence of comorbidityRef.Ref.Ref.Ref.
 Gastroesophageal reflux1.578b1.1180.4774.149
 Ischemic heart disease-1.104d0.979-0.476-0.198
 Hypertension0.0982.4731.249-6.218e
 Past myocardial infarction1.4095.4949.143-9.305
 Arrhythmia0.674-6.298a5.589e-15.852a
 Heart failure0.830-0.0310.993-7.320
 Past cerebrovascular event-0.404-3.174-1.922-6.255
 Osteoporosis-1.5080.213-0.1834.052
 Diabetes-0.431-0.235-3.067-1.123
 Glaucoma2.869-1.372-1-1
 Chronic bronchitis-1.341a2.583-2-2
Severity of symptoms in the past week
 Dyspnea at rest0.573c-1.286c0.150-1.302d
 Dyspnea during daily activities0.353c-0.3980.3510.808
 Cough0.508c0.4050.939a-0.143
 Sputum production, amount smallRef.Ref.Ref.Ref.
 Medium0.331-2.5870.1201.664
 Significant0.307-0.706-1.806-8.841
Use of short-acting bronchodilators in the past week (% all patients)
 ≤1Ref.Ref.Ref.Ref.
 2-30.0062.2583.870-11.269a
 >31.194-3.831d4.593a-6.393

a, b, c, d, e. 1: not analyzed due to missing data; 2: not assessed in the ACO group; Ref.: reference category.